Skip to content

Posttraumatic stress disorder with and without consequent addiction disorders: Putative differentiating role of the HPA-system

Posttraumatic stress disorder with and without consequent addiction disorders: Putative differentiating role of the HPA-system - PTSD Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010118
Enrollment
400
Registered
2016-08-08
Start date
2017-02-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F43.1 F43.8 F10 F11 F12 F13 F14 F15 F16 F17 F18 F19

Interventions

Group 1: Case group 1: PTBS patients with dependence disorder. Taking of a blood sample to determine the genetic material in the stress hormone system and collection of anamnestic data, self-report qu

Sponsors

Fachklinik St. Marienstift Dammer Berge
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - ICD-10 Diagnosis PTBS - Additional addiction diagnosis according to ICD-10 or no additional addiction diagnosis according to ICD-10 - Sufficient understanding of language to fill in the questionnaires in German or with a interpreter via the mother tongue - Completed detoxification

Exclusion criteria

Exclusion criteria: - Additional ICD-10 diagnosis of Schizophrenia - Additional ICD-10 diagnosis of intelligence impairment - Additional ICD-10 diagnosis of dementia - Physical impairment/disease that renders study participation unlikely - grave anemia, hb below 9 mg/dl, erythrozyten below 3/pl in peripheral blood

Design outcomes

Primary

MeasureTime frame
The end of participation will be reached if participants complete the following study parts: Taking of the blood sample, anamnesis and completion of all questionnaires and psychological tests. Collection of data will take approximately 8 weeks (due to the variable schedule of taking the blood sample), at a maximum the duration of the therapy. Primary outcome is the blood sample to identify the genetic material in the stress hormone system.

Countries

Germany

Contacts

Public ContactDunja Hinze-Selch

Fachklinik St. Marienstift Dammer Berge

dunja.hinze-selch@sucht-fachkliniken.de054935020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026